enGene Holdings Inc. Common Stock (ENGN : NASDAQ)
Common Stock
Follow ENGN
ENGN
enGene Holdings Inc. Common Stock
WealthAwesomePerformance
1 Day
+26.67%
1 Week
+35.71%
1 Month
+39.88%
YTD
+31.03%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$111.92M
52W High
$12.25
52W Low
$1.40
P/E Ratio
-
50 Day MA
$1.77
200 Day MA
$4.07
Beta
-0.24
Dividend Yield
-
Performance history
ENGN returns since 2026
enGene Holdings Inc. Common Stock has traded since Jun 2026 in our data. Its deepest fall was −29.3% (Sep 2026 to Nov 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*+31.0%
* Partial year (first year of data, or year to date).
$10,000 invested in ENGN
- 2026 (start of our data)$13,103
- All-time high in our data
- $2 on Nov 12, 2026 · at the high
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past ENGN? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/12/2026 | $1.93 | $2.35 | $1.90 | $2.28 | $2.28 | 11,856,200 |
| 11/11/2026 | $1.70 | $1.81 | $1.63 | $1.80 | $1.80 | 2,360,845 |
| 11/10/2026 | $1.76 | $1.76 | $1.63 | $1.67 | $1.67 | 741,183 |
| 11/9/2026 | $1.75 | $1.80 | $1.70 | $1.77 | $1.77 | 848,598 |
| 11/6/2026 | $1.68 | $1.77 | $1.63 | $1.75 | $1.75 | 1,426,900 |
| 11/5/2026 | $1.70 | $1.71 | $1.65 | $1.68 | $1.68 | 623,472 |
| 11/4/2026 | $1.58 | $1.75 | $1.57 | $1.72 | $1.72 | 1,445,500 |
| 11/3/2026 | $1.47 | $1.63 | $1.45 | $1.62 | $1.62 | 937,116 |
| 11/2/2026 | $1.55 | $1.55 | $1.45 | $1.45 | $1.45 | 587,186 |
| 10/30/2026 | $1.53 | $1.55 | $1.46 | $1.53 | $1.53 | 1,186,100 |
Analyst Price Targets
Based on 9 analysts covering ENGN · as of Oct 26, 2026
Wall Street analysts forecast ENGN stock price to rise 44.1% over the next 12 months.
Consensus
Buy3.56 / 5.00
Avg. Target
US$3.29
+44.1% Upside
Current Price
US$2.28
Last close
Analyst Breakdown (9 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ENGN's historical volatility
30-Day Vol
99.3%
Annualized
90-Day Vol
68.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$2.73
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$2.42 | US$1.72 – US$3.41 |
| 60 trading days | US$2.57 | US$1.58 – US$4.17 |
| 90 trading days | US$2.73 | US$1.51 – US$4.93 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About enGene Holdings Inc. Common Stock
enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-135.93M
- Profit Margin
- 0.00%
- ROE (TTM)
- -60.50%
- EPS (Diluted)
- -2.07
- Book Value
- 3.44
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About ENGN.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $2.27 | +118.27% |
| ICMB | Investcorp Credit Management BDC Inc | $1.06 | +71.49% |
| BGIN | Bgin Blockchain Limited Class A Ordinary Shares | $2.76 | +49.19% |
| TGHL | The GrowHub Limited Class A Ordinary Shares | $0.53 | +31.81% |
| PLBL | Polibeli Group Ltd Class A Ordinary Shares | $7.27 | +28.79% |
| WKSP | Worksport Ltd | $0.35 | +25.94% |
| AUC | ATIF Holdings Limited | $6.51 | +24.24% |
| USEA | United Maritime Corporation | $3.02 | +22.76% |
Free with a Wealth Awesome account
Keep analysing ENGN, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.